https://www.selleckchem.com/pr....oducts/tiplaxtinin-p
In value-based health care delivery, radiation oncologists need to compare empiric costs of care delivery with advanced technologies, such as intensity-modulated proton therapy (IMPT) and intensity-modulated radiation therapy (IMRT). We used time-driven activity-based costing (TDABC) to compare the costs of delivering IMPT and IMRT in a case-matched pilot study of patients with newly diagnosed oropharyngeal (OPC) cancer. We used clinicopathologic factors to match 25 patients with OPC who received IMPT in 2011-12 with 25 pati
Like
Comment
Share
